A Placebo Controlled, Randomized Double-blind Parallel Group 12-month Trial of Fasudil for the Treatment of Mild Cognitive Impairment Due to Alzheimer's disease, nested within a Multi-Arm Phase 2 Clinical Trial Platform

Research Categorization
Researcher and Organization
Principal Investigator
Principal Investigator First Name
Clive
Principal Investigator Last Name
Ballard
Awardee Organization
Contact PI Country
Project Detail
FY Overall Cost
$3,024,684
Funding Organization
Agency/Funding Organization
Funding Organization Country